-
of drug resistance, metastasis, and drug discovery in breast and kidney cancers in the laboratory of Dr. Sahin. The major research theme of the Sahin lab is to identify the mechanisms of drug resistance
-
publications in reputable journals. These positions will also include anti-obesity drug development and will provide the fellows opportunity to also learn early drug discovery and development approaches. Highly
-
related to fungal pathogenesis and antifungal drug resistance in human pathogenic Aspergillus species. The successful candidate will also be expected to take on administrative responsibilities related
-
involves drug discovery to target the epigenetic modifiers. We apply cutting-edge technologies, such as single-cell multi-omics, spatial transcriptomics, CUT&Tag, genome-wide CRISPR in vivo screening
-
drug discovery. To identify these pathways, the postdoctoral fellow will use human iPSC-derived neurons and cutting-edge approaches, including single-cell RNA-sequencing (perturb-seq), chromatin
-
insights in dynamics-based drug discovery. We have an opening for a postdoctoral associate with a focus on experimental work related to the structural biology of G Protein Coupled Receptor (GPCR) signaling
-
focuses on drug target discovery and novel therapy development to treat ocular vascular diseases, including diabetic retinopathy, wet age-related macular degeneration (AMD) and retinopathy of prematurity
-
Position Highlights: The lab has significant expertise and provides mentorship in the areas of p53/MDM2/MDMX phosphorylation signaling, ubiquitination, transcriptional regulation, and drug discovery using
-
Center of Excellence for Data-Driven Discovery in the Department of Structural Biology at St. Jude Children’s Research Hospital, the Babu Group seeks a highly driven, full-time experimental Lead